Milestone Improvements in the Management of Lethal Brain Cancer in Children, Parkinson’s Disease and Obsessive Compulsive Disorder Central Florida Based Mazor Robotics Celebrating 10,000 Procedures
Orlando, Florida (August 17, 2015) – Mazor Robotics (www.mazorrobotics.com), a global leader in the development and distribution of innovative surgical guidance systems for spine and brain surgery, announced that a doctor at the University Hospital of Tübingen in Germany completed the first transcerebellar brainstem biopsy using its Renaissance® Guidance System.
Affecting children exclusively, diffuse intrinsic pontine gliomas (DIPGs) are located in the brainstem and are the second most common malignancy of the brain in children. Until now, DIPG has remained incurable, with, according to literature, about 90% of children dying within two years of diagnosis. To develop effective new treatments on a molecular genetic basis, tissue samples are required. Brainstem biopsies are not standard and are very difficult to perform with standard equipment. “The groundbreaking biopsy of a DIPG utilizing a posterior trans-cerebellar approach was enabled by Renaissance technology. It is practically impossible to perform this procedure with most standard systems,” said Prof. Martin U. Schuhmann, After moving their US headquarters from New York to Orlando, Florida in 2012 they quickly gained recognition as one of the largest players in the state's fastest growing sectors of simulation, medical device and video gaming. From their offices atop the Plaza in downtown Orlando, they have become active in the local community in the
areas of healthcare, technology and education, including ongoing participation with Central Florida pediatric cancer charity, Kids Beating Cancer.
The world's first deep brain stimulation (DBS) procedure using the Mazor Robotics Renaissance Guidance System was performed in Orlando, Florida in August of 2013, creating a steady stream of life-changing stories from patients with conditions such a Parkinson’s Disease, Essential Tremor and Obsessive Compulsive Disorder.
About Mazor Robotics Mazor Robotics (TASE: MZOR; NASDAQGM: MZOR) believes in healing through innovation by developing and introducing revolutionary robotic-based technology and products aimed at redefining the gold standard of quality care. Mazor Robotics Renaissance® Guidance System enables surgeons to conduct spine and brain procedures in a more accurate and secure manner. For more information, please visit www.MazorRobotics.com. Additional Resources:
Milestone Improving Management in Pediatric Brain Cancer
Mazor Completes 10,000th Procedure
Renaissance Guidance System Helping Patients with OCD
Media Contact: Stephani Shipman Marketing Communications Manager Mazor Robotics, Inc. - s.shipman@mazorrobotics-us.com (407) 591-3468 ###